Shareholders Equity: The sum of preferred and common equity items.
Enzon Pharmaceuticals Inc. (ENZN) had Shareholders Equity of $42.08M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-1.60M |
|
-- |
|
-- |
|
$1.47M |
|
$-1.47M |
|
$0.43M |
|
$-1.04M |
|
$-1.04M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.47M |
|
$-1.47M |
|
74.22M |
|
74.22M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$42.81M |
|
-- |
|
-- |
|
$42.81M |
|
$0.73M |
|
-- |
|
-- |
|
$0.73M |
|
$-2.52M |
|
$42.08M |
|
|
Shareholders Equity |
$42.08M |
74.22M |
|
| Cash Flow Statement Financials | |
$-3.01M |
|
-- |
|
$-1.27M |
|
$46.86M |
|
$42.57M |
|
$-4.29M |
|
-- |
|
-- |
|
$-1.27M |
|
| Fundamental Metrics & Ratios | |
58.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
42.42% |
|
-2.54% |
|
-2.50% |
|
-2.54% |
|
$0.57 |
|
$-0.04 |
|
$-0.04 |
|